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Abstract We investigated whether endogenously or exogen-
ously produced nitric oxide (NO) can inhibit cellular glutathione
reductase (GR) via the formation of S-nitrosothiols to decrease
cellular glutathione (GSH) and increase oxidative stress in RAW
264.7 cells. The specificity of this inhibition was demonstrated by
addition of a NO-synthase inhibitor, and met- or oxyhemoglobin.
Using isolated GR we found that only certain NO donors inhibit
this enzyme via S-nitrosothiol. Furthermore, we found that
cellular GSH decrease is paralleled by an increase of superoxide
anion production. Our results show that the GR enzyme is a
potential target of S-nitrosothiols to decrease cellular GSH
levels and to induce oxidative stress in macrophages.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Nitric oxide (NO), a free radical generated by at least three
isoforms of NO synthase (NOS) has a remarkable range of
physiological and pathophysiological e¡ects. In some cases,
such as the liver high levels of nitric oxide synthesis are cyto-
protective while in other instances NO has cytostatic or cyto-
toxic e¡ects exempli¢ed by the microbicidal or tumoricidal
activity of NOS2 expressing cells [1]. The mechanism(s) by
which nitric oxide (NO) exerts its cytotoxic activities includes
suppression of DNA synthesis, profound reduction in protein
synthesis, inhibition of the mitochondrial transport chain, the
inhibition of GAPDH and cytochrome P450 activity as well as
apoptosis [1]. Many of these responses are associated with the
modi¢cation of proteins by NO itself or by physiological NO
carriers such as S-nitrosothiols (RSNO) or metal conjugates
[2]. One possible mechanism by which RSNO may exert its
(patho)physiological e¡ect is the inhibition of glutathione re-
ductase (GR) and glutathione S-transferase [3^7]. It has been
well established that the intracellular £avoenzyme glutathione
reductase recycles oxidized glutathione (GSSG) to maintain
high levels of reduced glutathione (GSH) which is important
in the detoxi¢cation processes of various cells. Increased ox-
idative stress or reduced cell proliferation has been observed
after endogenous and exogenous applied NO and associated
with diminished levels of total GSH [8^11]. In the same line of
evidence, it was demonstrated that S-nitrosoglutathione and
diglutathionyl-dinitroso-iron (DINC-[GSH]2), two major car-
riers of NO, can inhibit the enzyme GR through the oxidation
of the Cys-63 site of the enzyme [6]. However, all GR inhibi-
tion studies presented so far used the isolated enzyme. There-
fore, the aim of the present study was to investigate whether
endogenously or exogenously produced NO can inhibit cellu-
lar glutathione reductase via the formation of RSNO to de-
crease cellular glutathione levels and increase oxidative stress
in the murine macrophage cell line RAW 264.7.
2. Materials and methods
2.1. Cell culture conditions
The mouse macrophage cell line RAW 264.7 was obtained from
ATCC, Rockville, MD, USA. Cells were cultured in 60 mm Petri
dishes in William’s medium E, containing calf serum, penicillin/strep-
tomycin, HEPES, insulin (GIBCO BRL, Paisley, Scotland), hydro-
cortisone and sodium-pyruvate (Sigma, Deisenhofen, Germany), in
a humidi¢ed atmosphere of 5% CO2 and 95% air at 37‡C [12]. En-
dogenous NO production was generated with 200 U/ml rat recombi-
nant interferon-Q (IFN-Q ; Genzyme, Cambridge, MA, USA), and
5 Wg/ml lipopolysaccharide (LPS, from Escherichia coli 0111:B4, Sig-
ma), in the presence of L-arginine and in the absence of CS and
hydrocortisone. Inhibition of NO-synthase activity was performed
using 1 mM NGmonomethyl-L-arginine (NMA, Sigma). In order to
scavenge NO, cell cultures were simultaneously incubated with either
methemoglobin or oxyhemoglobin (Sigma). Extracellular NO produc-
tion was generated using S-nitroso-N-acetylpenicillinamine (SNAP),
S-nitroso-L-glutathione (SNOG, Alexis, Germany), S-nitroso-L-gluta-
thione-monoethylester (SNOG-MEE, Alexis), S-nitroso-cysteine
(SNOC, [13]), or diethylenetriamine/nitric oxide (DETA/NO) at var-
ious concentrations. In addition, we incubated macrophages with a
reactive oxygen intermediate (ROI) generating system (1 mM hypo-
xanthine and 0.5 U/ml xanthine-oxidase, Boehringer, Mannheim, Ger-
many). In order to accentuate the protective contribution of GSH in
cellular damage following oxidative stress we depleted GSH from cells
with 0.2 mM L-buthionine sulfoxime (BSO, Sigma) and measured the
formation of NO derivatives, and reactive oxygen intermediates.
2.2. Determination of NO32 plus NO
3
3, S-nitrosothiols, and lactate
dehydrogenase (LDH) leakage in supernatants
Cell culture supernatants were assayed for the stable end products
of NO oxidation (NO32 plus NO
3
3 ) and RSNO levels using modi¢ed
procedures based on the Griess reaction as recently described [14]. In
order to evaluate the cellular damage following various treatments,
supernatants were measured for LDH leakage using a Cobas Bio
autoanalyzer (Ho¡mann La Roche, Basel, Switzerland). In addition,
cell viability was determined by a routine trypan blue exclusion assay.
2.3. Determination of intra- and extracellular glutathione reductase
(GR) enzyme activity
GR enzyme activity was determined in cell pellets and culture
supernatants using the method recently published by Becker et al.
[3]. In order to verify whether the inhibition of GR by NO donors
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is an oxidative process we incubated GR plus NO donors with 10.0
mM DTT as recently described [6].
2.4. Determination of total intra- and extracellular GSH levels
For evaluating total intra- and extracellular GSH levels (represent-
ing GSH+GSSG), cell pellets were resuspended in 1 ml metaphos-
phoric acid bu¡er (3%), centrifuged and aliquots of the supernatants
were adjusted to pH 7.5^8.0 with K2CO3 (cell pellets were used for
protein determination). Total cellular GSH was assayed by a modi¢ed
method reported by Gri⁄th [15] using an enzymatic recycling proce-
dure in which reduced GSH was sequentially oxidized by 5,5P-dithio-
bis-(2-nitrobenzoic-acid) (DTNB) to GSSG which is then reduced by
NADPH back to GSH in the presence of glutathione reductase to
react again with DTNB. The rate of DTNB formation is monitored
at 412 nm and the glutathione present was evaluated from a standard
curve. GSSG was determined by ¢rst masking reduced GSH with
2-vinylpyridine, then GSSG was measured as described above. Oxi-
dized and reduced GSH, that may be released in the supernatant were
measured in the same way. All data were normalized per mg protein.
2.5. Determination of superoxide in cell culture supernatants
The release of superoxide (O:32 ) in the medium was measured spec-
trophotometrically by monitoring the superoxide dismutase inhibit-
able reduction of 160 WM ferricytochrome c at 550 nm at 37‡C.
One mol O:32 reduces 1 mol ferricytochrome c [16].
2.6. Statistical analysis
Values are expressed as mean þ S.E.M. Signi¢cance of di¡erences
was determined by using the Anova test (Statview statistics program,
Abacus Concept, Inc.). Statistical signi¢cance was established at a P
value 6 0.05.
3. Results
3.1. Diminished cellular GSH levels and GR enzyme activity
after endogenous NO production or exogenously produced
reactive oxygen intermediates
Recent evidence suggests that induction of the inducible
NOS isoform has a potent e¡ect on the cellular GSH content
[16]. We found that the increase of NOx (nitrite+nitrate, and
RSNO) production (Fig. 1A) in RAW cell supernatant after
LPS+IFNQ incubation parallels a decrease of both the total
cellular GSH (Fig. 1B) levels and the GR enzyme activity
(Fig. 1B). In addition, we observed an increased LDH mem-
brane leakage after stimulation with LPS+IFNQ (Fig. 1C).
The treatment of RAW cells with LPS+IFNQ leads to cell
death of 20 þ 2.4% when compared to untreated cells. In order
to prove whether NO is directly linked to the cellular loss of
GSH levels and a reduction in GR enzyme activity, cell cul-
tures were simultaneously incubated with NMA, met- and
oxyhemoglobin. As depicted in Fig. 2 we found that either
NMA, met- or oxyhemoglobin could partially reconstitute the
LPS+IFNQ-induced loss of GSH and GR enzyme activity. In
addition, we measured whether GSH levels or GR activity
could be determined in culture supernatants. As shown in
Table 1 we found no di¡erences in GSH levels between the
supernatants of control cultures and IFNQ+LPS or
IFNQ+LPS+NMA treated cell cultures. In addition, we were
unable to detect any GR activity in the supernatant. Like the
NO-mediated cellular loss of GSH and GR activity, we ob-
served that ROI generating compounds can equally deplete
the cellular GSH content (2.04 þ 0.9 vs. 1.1 þ 0.5), and GR
enzyme activity (8.5 þ 1.5 vs. 4.1 þ 1.2).
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Fig. 1. Endogenous nitric oxide (NO) production (A) is directly linked to loss of the cellular glutathione levels (GSH, B), glutathione reductase
activity (GR, B) and increased cell injury (C). RAW 264.7 cells were exposed either to LPS+IFN-Q or medium alone (Ctrl) for 24 h. Then,
supernatants were taken for determination of nitrite/nitrate (NO32 /NO
3
3 ), S-nitrosothiols (RSNO), and lactate dehydrogenase (LDH). Cells were
pelleted, washed twice and resuspended either in 3% metaphosphoric acid for GSH or in potassiumphosphate-EDTA bu¡er for GR assay. Re-
sults are expressed as the mean þ S.E.M. of the determination on three separate experiments.
Fig. 2. Raw 264.7 cells were exposed for 24 h either to normal me-
dium (Ctrl) or LPS/IFNQ in the presence or absence of NMA, oxy-
hemoglobin, and methemoglobin. Cellular GSH levels were deter-
mined as a direct result of GR inhibition caused by LPS/IFNQ. In
the presence of NMA, oxyhemoglobin or methemoglobin the inhibi-
tion of GR activity, and GSH levels were partially restored. Results
are expressed as mean of triplicates þ S.E.M. of four separate experi-
ments.
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3.2. Depletion of GSH leads to reduced NO levels but increased
superoxide formation
Several recent publications have shown that the exposure of
cells to NO leads to GSH depletion and reduced cell growth
[9^11,17]. It is thought that one consequence of the GSH
depletion is an increased oxidative stress. Therefore, we have
investigated the formation of nitrite/nitrate, and superoxide in
culture supernatants after LPS+IFNQ exposure in the presence
or absence of BSO (inhibitor of the Q-glutamylcysteine syn-
thase). As shown in Fig. 3 the cellular depletion of GSH
(0.2 þ 0.1 nmol/mg prot. vs non-depletion 2.0 þ 0.4) leads to
a signi¢cant (P6 0.01) loss of nitrite/nitrate production (Fig.
3A) while simultaneously a signi¢cant (P6 0.01) increase of
superoxide anion (Fig. 3B) formation was observed.
3.3. Decrease of cellular GSH and GR enzyme activity by
various NO donors in RAW 264 cells
Various NO donors have been reported to interfere directly
or indirectly with cellular GSH [10,18]. As shown in Fig. 4
various NO donors decrease both the cellular GSH contents
and the GR enzyme activity between 60 and 95% (Fig. 4A)
while their parent compounds have no signi¢cant inhibitory
activity (data not shown). In addition, it was observed that all
NO donors lead to a sharp increase of membrane leakage
measured as a LDH release in the supernatant (Fig. 4B)
and cell death of about 80% (Table 1). Cell lysis can lead to
the loss of cellular GSH and GR through leakage from the
cells when cell viability is reduced. Therefore, we have deter-
mined whether the loss of cellular GSH and GR activity could
be found in the supernatants of NO donor treated cells. As
shown in Table 1 some parts of the diminished cellular GSH
levels can be explained by the leakage of GSH and GSSG in
the supernatant. However, the sum of intra- and extracellular
GSH in NO donors treated cell cultures was not equal to the
amount found in untreated control cultures. Only when cells
were exposed to GSNO high amounts of GSH and GSSG
were found in the supernatant. In addition, we found no ex-
tracellular GR activity in culture supernatants of NO donor
treated cell cultures. The sum of intra- and extracellular GR
activity was not equal to the amount found in control cul-
tures. We concluded from these results that the loss of cellular
GSH and GR through simple leakage from the cells repre-
sents only a small portion and that GR is inhibited by S-
nitrosothiols.
3.4. SNOC and SNOG but not DETA/NO and SNAP inhibit
the isolated GR enzyme activity
Several authors have suggested that the formation of S-ni-
trosothiols is necessary to inhibit the GR enzyme activity [4^
7]. Since we have shown in Fig. 4 that all investigated NO
donors inhibit the cellular GR enzyme activity in RAW 264.7
cells we investigated whether they would also exert an inhib-
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Table 1
Intra- and extracellular GSH/GSSG levels, and GR activity in RAW 264.7 cell cultures
Treatment Intracellular
GSH
(nmol/mg prot.)
Intracellular
GSSG
(nmol/mg prot.)
Extracellular
GSH
(nmol/mg prot.)
Extracellular
GSSG
(nmol/mg prot.)
Intracellular
GR activity
(mU/mg prot.)
Extracellular
GR activity
(mU/mg prot.)
Cell
viability
(%)
Control 3.4 þ 0.7 6 a 1.52 þ 0.3 0.08 þ 0.05 11.8 þ 1.5 6 a 95.6 þ 0.5
IFNQ+LPS 1.2 þ 0.2 6 1.39 þ 0.25 0.11 þ 0.1 3.7 þ 0.9 6 75.3 þ 3.6
IFNQ+LPS+NMA 2.5 þ 0.3 6 1.34 þ 0.1 0.06 þ 0.05 7.7 þ 1.8 6 82.0 þ 2.5
SNOG 0.9 þ 0.4 6 n.d. 3.1 þ 0.6 4.8 þ 1.3 6 23.3 þ 1.5
SNOC 0.4 þ 0.1 6 3.45 þ 0.5 0.3 þ 0.1 6.5 þ 1.2 6 18.6 þ 3.5
SNAP 1.2 þ 0.2 6 2.35 þ 0.2 0.6 þ 0.1 5.7 þ 1.0 6 23.0 þ 2.3
aBelow detection limit; n.d., not done.
Cells were exposed for 24 h either to SNOG (1 mM), SNOC (1 mM), SNAP (1 mM), IFNQ+LPS, IFNQ+LPS+NMA or medium alone (Control).
Then, GSH (reduced and oxidized GSH) and GR activity were determined as described. All data were normalized per mg protein. Results are
expressed as mean of triplicates þ S.E.M. of three separate experiments.
Fig. 3. Increased superoxide anion (O:32 ) formation in RAW 264.7 cells after GSH depletion. Cells were depleted of GSH with 0.2 mM L-butio-
nine sulfoximine (BSO), then cell cultures were exposed to LPS/IFN-Q for 12 h and 24 h. Then, we measured O:32 production (B) and NO
3
2 /
NO33 levels (A) at the same time points as described. Results are expressed as mean of triplicates þ S.E.M. of three separate experiments.
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itory e¡ect on the isolated enzyme. We found that DETA/NO
and SNAP do not inhibit signi¢cantly (Ps 0.05) the GR en-
zyme activity while the S-nitrosothiols SNOC and SNOG
showed an inhibition of approximately 40%. Recently, Becker
et al. have reported that the presence of albumin would be
necessary in order to stabilize recombinant human GR to
achieve inhibition by S-nitrosoglutathione [3]. We found
that the addition of albumin to SNOG (Fig. 5A) and
SNOG (Fig. 5B) reduces the inhibitory e¡ects of both NO
donors towards the enzyme activity of GR signi¢cantly
(P6 0.05) by approximately 50% independently of the NO
donor concentration. Furthermore, we investigated whether
the inhibition of GR enzyme activity is an oxidative process
as recently suggested [6]. We found that a simultaneous 2 h
incubation of GR with SNOC and 10 mM DTT partially
reversed the SNOC-induced inhibition of GR enzyme activity
(17.8 þ 1.0% vs. 3.1 þ 0.8% in the presence of DTT).
4. Discussion
In recent years numerous publications have demonstrated a
link between nitric oxide production, cellular damage, and the
cellular glutathione content [10,11,18,19]. The consequence of
a decrease in cellular GSH levels is an increase of reactive
oxygen intermediates leading to oxidative stress and potent
cellular damage [20,21]. The mechanisms of ROI and/or
NOI-mediated cellular damage include suppression of DNA
and protein synthesis, inhibition of the mitochondrial electron
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Fig. 4. RAW 264.7 cells were incubated with various NO donors at 1 mM for 24 h. All NO donors down regulated the cellular GSH contents,
and GR enzyme activity (A). In addition, we observed increased cell injury in the supernatants (B) as compared with untreated control cultures
(Ctrl). Results are the mean of triplicates þ S.E.M. of three separate experiments.
Fig. 5. Inhibition of recombinant glutathione reductase in the presence or absence of 5 mg/ml bovine serum albumin (BSA) in a glutathione re-
ductase standard assay as described above. Recombinant glutathione reductase (2.5 U/ml) was incubated with S-nitroso-glutathione (SNOG),
and S-nitroso-cysteine (SNOC) in a concentration range of 0.1 to 5 mM in the presence of 1 mM NADPH in a total incubation volume of
1 ml. Aliquots were taken after 1 h and assayed for GR enzyme activity. Both SNOG and SNOC showed a dose-dependent inhibition of the
GR enzyme activity. However, addition of BSA to the incubation mixture resulted in a reduced inhibition of recombinant GR enzyme activity.
Results are expressed as the mean of triplicates þ S.E.M. of three separate experiments.
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transport chain and apoptosis [1,21]. The modi¢cation of pro-
teins by radicals is associated with the formation of S-nitro-
sothiols or metal conjugates [2]. Recently, several investigators
shed light upon possible pathophysiological mechanisms of
how S-nitrosylation of proteins may interfere with glutathione
metabolism [5,6]. It was observed that the formation of S-
nitrosoglutathione and DINC-GSH can inhibit the enzyme
glutathione reductase and glutathione S-transferase [3^7]. In
the present study, we show that endogenously or exogenously
produced nitric oxide can inhibit cellular glutathione reduc-
tase activity via the formation of S-nitrosothiols. Further-
more, we demonstrated that the inhibition of NOS by the L-
arginine analogue NMA or by trapping nitric oxide by met-
and oxyhemoglobin can partially reverse the inhibition of glu-
tathione reductase activity and consequently the loss of cellu-
lar GSH levels. This suggests that the presence of hemoglobin
in the blood may function as a control mechanism of NO
overproduction in order to control cellular damage.
Furthermore, in the present study we show that a decrease
in cellular GSH levels parallels the decrease of NO produc-
tion. This observation is not surprising since Stuehr et al.
demonstrated that GSH is a potent co-factor for NOS enzyme
activity [22]. Thus, it seems conceivable to assume that NO
regulates its own enzyme activity through various negative
feedback mechanisms [23,24], including the depletion of cel-
lular GSH to diminish NOS activity. The latter reaction might
be of interest in the treatment of chronic in£ammatory dis-
eases such as arthritis [25] where continuous NO overproduc-
tion leads to potent cellular damage. It was also demonstrated
that the inhibition of NOS by oral application of NMA im-
proved murine autoimmune arthritis by reducing cellular
damage [26]. Whether this treatment also improves the cellu-
lar GSH synthesis thus reducing oxidative stress in chronic
in£ammation needs to be further elucidated. Although the
bene¢cial or detrimental role of NO in various in£ammatory
diseases is still a matter of debate, it seems that cellular GSH
closely controls both the production of toxic ROI and the NO
production. In support of this conclusion, we found that low-
er levels of cellular GSH lead to increased oxidative stress and
subsequent increased cellular damage.
Acknowledgements: We wish to thank Prof. L. Keefer of the Labo-
ratory of Comparative Carcinogenesis, National Cancer Institute,
Frederick Cancer Research and Development Center, Frederick,
MD, USA for providing the NO donor DETA/NO and for critical
comments on the manuscript. This investigation received ¢nancial
assistance from the UNDP/World Bank/WHO Special Program for
Research and Training in Tropical Disease (TDR ID 960425), a grant
of the Klinik Foºrderung of the University of Ulm P-453, and the
BMBF, IZKF-Ulm/A2.
References
[1] Kroºncke, K.-D., Fehsel, K. and Kolb-Bachofen, V. (1995) Biol.
Chem. 376, 327^343.
[2] Stamler, J.S. (1994) Cell 78, 931^936.
[3] Becker, K., Gui, M. and Schirmer, R.H. (1995) Eur. J. Biochem.
234, 472^478.
[4] Boese, M., Keese, M.A., Becker, K., Busse, R. and Muºlsch, A.
(1997) J. Biol. Chem. 272, 21767^21773.
[5] Stamler, J.S. and Hausladen, A. (1998) Nat. Struct. Biol. 5, 247^
249.
[6] Becker, K., Savvides, S.N., Keese, M., Schirmer, R.H. and Kar-
plus, P.A. (1998) Nat. Struct. Biol. 5, 267^271.
[7] Keese, M.A., Boese, M., Muºlsch, A., Schirmer, R.H. and Becker,
K. (1997) Biochem. Pharmacol. 54, 1307^1313.
[8] Ceballos-Picot, I., Witko-Sarsat, V., Merad-Boudia, M., Nguyen,
A.T., TheŁvenin, M., Jaudon, M.C., Zingra¡, J., Verger, C.,
Jungers, P. and Descamps-Latscha, B. (1996) Free Radic. Biol.
Med. 21, 845^853.
[9] Walker, M.W., Kinter, M.T., Roberts, R.J. and Spitz, D.R.
(1995) Pediatr. Res. 37, 41^49.
[10] Bolanos, J.P., Heales, S.J.R., Peuchen, S., Barker, G.E., Land,
J.M. and Clark, J.B. (1996) Free Radic. Biol. Med. 21, 995^1001.
[11] Luperchio, S., Tamir, S. and Tannenbaum, S.R. (1996) Free
Radic. Biol. Med. 21, 513^519.
[12] Nussler, A.K., Billiar, T.R., Liu, Z.Z. and Morris Jr., S.M.
(1994) J. Biol. Chem. 269, 1257^1261.
[13] Kroºncke, K.-D. and Kolb-Bachofen, V. (1996) Methods Enzy-
mol. 269, 279^284.
[14] Marzinzig, M., Nussler, A.K., Stadler, J., Marzinzig, E., Bartlen,
W., Morris Jr., S.M., Nussler, N.C., Beger, H.G. and Bruºckner,
U.B. (1997) Nitric Oxide Biol. Chem. 1, 177^189.
[15] Gri⁄th, O.W. (1980) Anal. Biochem. 106, 207^212.
[16] Shu, Z., Jung, M., Beger, H.G., Marzinzig, M., Han, F., Butzer,
U., Bruºckner, U.B. and Nussler, A.K. (1997) Am. J. Physiol. 273,
G1118^G1126.
[17] Petit, J.-F., Nicaise, M., Lepoivre, M., Guissani, A. and Lemaire,
G. (1996) Biochem. Pharmacol. 52, 205^212.
[18] Minamiyama, Y., Takemura, S., Koyama, K., Yu, H., Miyamo-
to, M. and Inoue, M. (1996) Am. J. Physiol. 271, G575^G581.
[19] Harbrecht, B.G., Di Silvio, M., Chough, V., Kim, Y.-M., Sim-
mons, R.L. and Billiar, T.R. (1997) Ann. Surg. 225, 76^87.
[20] Tribble, D.L. and Jones, D.P. (1990) Biochem. Pharmacol. 39,
729^736.
[21] Wiseman, H. and Halliwell, B. (1996) Biochem. J. 313, 17^29.
[22] Stuehr, D.J., Kwon, N.S. and Nathan, C.F. (1990) Biochem.
Biophys. Res. Commun. 168, 558^565.
[23] Assreuy, J., Cunha, F.Q., Liew, F.Y. and Moncada, S. (1993) Br.
J. Pharmacol. 108, 833^837.
[24] Rogers, N.E. and Ignarro, L.J. (1992) Biochem. Biophys. Res.
Commun. 189, 242^249.
[25] Clair, E.W.S., Wilkinson, W.E., Lang, T., Sanders, L., Misuko-
nis, M.A., Gilkeson, G.S., Pisetsky, D.S., Granger, D.L. and
Weinberg, J.B. (1996) J. Exp. Med. 184, 1173^1178.
[26] Weinberg, J.B., Granger, D.L., Pisetsky, D.S., Seldin, M.F.,
Misukonis, M.A., Mason, S.N., Pippen, A.M., Ruiz, P., Wood,
E.R. and Gilkeson, G.S. (1994) J. Exp. Med. 179, 651^660.
FEBS 21610 2-3-99
U. Butzer et al./FEBS Letters 445 (1999) 274^278278
